Diffuse reflectance spectroscopy
Zenalux Biomedical, NC, United States
Zenalux has developed a patent-protected, photonic system that quickly and non-destructively measures important biomarkers including hemoglobin concentration, hemoglobin saturation and scattering (a measure of cell density and necrosis). The technique can be applied more widely to any turbid media beyond biological systems.
Primary Application Area: Medical Devices
Technology Development Status: Ready to Market
Technology Readiness Level: TRL 6
FIGURES OF MERIT
Value Proposition: Diffuse reflectance spectroscopy, coupled with our patented monte carlo-based algorithm, enables real-time, non-destructive biological tissue diagnostics. This technology can displace slow, more costly and invasive diagnostic methods for a variety of cancers and can be deployed for point-of-care testing.
Organization Type: Mid-stage Startup (A or B)
Showcase Booth #: 36M
GOVT/EXTERNAL FUNDING SOURCES
Government Funding/Support to Date:
Primary Sources of Funding: Federal Grant
Looking for: Both Funding and Development Partners